CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $14.45M, lower than 95% of all stocks globally
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
10.70MGBP14.45M · vs all stocks (USD)
Revenue (TTM)
6.22MEUR8.40M · vs all stocks (USD)
Profit Margin
-60.20%vs Specialty Chemicals peers
Beta
1.03xvs all stocks
52-Week Change
57.69%vs all stocks
Market Capitalization
10.70MGBP14.45M · vs all stocks (USD)
Enterprise Value
8.43MGBP11.38M · vs all stocks (USD)
Forward P/E
-3.42xvs Specialty Chemicals peers
Price to Sales (TTM)
1.49xvs Specialty Chemicals peers
Price to Book (MRQ)
2.29xvs Specialty Chemicals peers
Enterprise to Revenue
1.35xvs Specialty Chemicals peers
Enterprise to EBITDA
-2.54xvs Specialty Chemicals peers
Profit Margin
-60.20%vs Specialty Chemicals peers
Operating Margin
-39.45%vs Specialty Chemicals peers
Return on Assets (TTM)
-26.18%vs Specialty Chemicals peers
Return on Equity (TTM)
-83.24%vs Specialty Chemicals peers
Revenue (TTM)
6.22MEUR8.40M · vs all stocks (USD)
Revenue per Share (TTM)
0.0690EURUpdated Jul 9, 2026Quarterly Revenue Growth
15.10%vs Specialty Chemicals peers
Gross Profit (TTM)
3.26MEUR4.40M · vs all stocks (USD)
EBITDA (TTM)
-3.32MEUR-4.49M · vs all stocks (USD)
Net Income (TTM)
-3.74MEUR-5.06M · vs all stocks (USD)
Operating Cash Flow (TTM)
-2.97MEUR-4.01M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
453.67KEUR612.69K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Specialty Chemicals peers
Minority Interest (Equity)
73.53KEURFY2024 · Dec 31, 2024Revenue
6.66MEURFY2024 · Dec 31, 2024Cost of Goods Sold
2.86MEURFY2024 · Dec 31, 2024Gross Profit
3.80MEURFY2024 · Dec 31, 2024Operating Income
-5.00MEUR-5.77M · vs all stocks (USD)
Pre-tax Income
-5.37MEURFY2024 · Dec 31, 2024Income Tax Expense
0.00EURFY2024 · Dec 31, 2024Net Income
-5.37MEURFY2024 · Dec 31, 2024EBIT
-5.21MEURFY2024 · Dec 31, 2024EBITDA (Income Statement)
-3.61MEURFY2024 · Dec 31, 2024Selling, General & Administrative
2.66MEURFY2024 · Dec 31, 2024Other Operating Expenses
511.63KEURFY2024 · Dec 31, 2024Non-operating Interest Income
87.73KEURFY2024 · Dec 31, 2024Non-operating Interest Expense
162.39KEURFY2024 · Dec 31, 2024EPS (Basic)
-0.0600EURFY2024 · Dec 31, 2024EPS (Diluted)
-0.0600EURFY2024 · Dec 31, 2024Basic Shares Outstanding
85.47MSharesFY2024 · Dec 31, 2024Diluted Shares Outstanding
85.47MSharesFY2024 · Dec 31, 2024Net Income from Continuing Operations
-5.37MEURFY2024 · Dec 31, 2024Minority Interests (P&L)
233.88KEURFY2024 · Dec 31, 2024Preferred Stock Dividends
0.00EURFY2024 · Dec 31, 2024Operating Cash Flow
-3.02MEURFY2024 · Dec 31, 2024Free Cash Flow
-3.12MEURFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
4.98MEURFY2024 · Dec 31, 2024Starting Profit (CF Statement)
-5.37MEURFY2024 · Dec 31, 2024Stock-based Compensation
-76.74KEURFY2024 · Dec 31, 2024Other Non-cash Items
-42.38KEURFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
2.62MEURFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
-148.52KEURFY2024 · Dec 31, 2024Capital Expenditures
-100.55KEURFY2024 · Dec 31, 2024Net Intangibles (CF)
-247.45KEURFY2024 · Dec 31, 2024Net Acquisitions
-1.50MEURFY2024 · Dec 31, 2024Net Investing Cash Flow
-1.60MEURFY2024 · Dec 31, 2024Long-term Debt Issuance
1.17MEURFY2024 · Dec 31, 2024Long-term Debt Payments
-1.74MEURFY2024 · Dec 31, 2024Net Financing Cash Flow
6.93MEURFY2024 · Dec 31, 2024Shares Outstanding
104.42MSharesUpdated Jul 9, 2026Float Shares
43.45MSharesUpdated Jul 9, 2026% Held by Insiders
58.28%vs all stocks
% Held by Institutions
24.98%vs all stocks
Total Cash (MRQ)
2.58MEUR3.48M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0280EURUpdated Jul 9, 2026Total Debt (MRQ)
1.67MEUR2.26M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3530xvs Specialty Chemicals peers
Current Ratio (MRQ)
2.04xvs Specialty Chemicals peers
Book Value per Share (MRQ)
0.0448EURUpdated Jul 9, 2026Total Assets
11.74MEUR13.55M · vs all stocks (USD)
Total Current Assets
7.60MEURFY2024 · Dec 31, 2024Total Liabilities
4.59MEURFY2024 · Dec 31, 2024Total Non-current Assets
4.14MEURFY2024 · Dec 31, 2024Total Non-current Liabilities
1.51MEURFY2024 · Dec 31, 2024Total Current Liabilities
3.08MEURFY2024 · Dec 31, 2024Cash
4.98MEURFY2024 · Dec 31, 2024Cash & Cash Equivalents
4.98MEURFY2024 · Dec 31, 2024Accounts Receivable
1.23MEURFY2024 · Dec 31, 2024Inventory
686.02KEURFY2024 · Dec 31, 2024Accounts Payable
1.31MEURFY2024 · Dec 31, 2024Short-term Debt
1.03MEURFY2024 · Dec 31, 2024Long-term Debt
1.30MEURFY2024 · Dec 31, 2024Common Stock (Book)
318.62KEURFY2024 · Dec 31, 2024Retained Earnings
-39.73MEURFY2024 · Dec 31, 2024Total Shareholders' Equity
7.15MEUR8.25M · vs all stocks (USD)
52-Week Low
6.00GBXUpdated Jul 9, 202652-Week High
24.00GBXUpdated Jul 9, 202652-Week Change
57.69%vs all stocks
Beta
1.03xvs all stocks
50-Day MA
13.51GBXUpdated Jul 9, 2026200-Day MA
10.93GBXUpdated Jul 9, 2026Avg 10-Day Volume
36.38KSharesUpdated Jul 9, 2026Avg 30-Day Volume
119.82KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
-0.0300EURUpdated Jul 9, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $14.45M, lower than 95% of all stocks globallySignificant
Market cap (USD): 14,454,617.762Global P5: 269,387,740.27
Revenue is $8.4M, lower than 95% of all stocks globallySignificant
Revenue (USD): 8,397,748.15Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Eenergy Group Plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Clean Power Hydrogen plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Airea plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eco Buildings Group plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
CelLBxHealth plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Kropz PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
Genedrive Plc
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Northern Bear Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Light Science Technologies Holdings plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Haydale Graphene Industries plc
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
3 interpretationsDecline With Range Expansion And DrawdownCash Elevated Relative to Current Liabilities and Total AssetsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Sealsq Corp
3 interpretationsDecline With Range Expansion And DrawdownCash Elevated Relative to Current Liabilities and Total AssetsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Fulcrum Therapeutics Inc.
3 interpretationsDecline With Range Expansion And DrawdownCash Elevated Relative to Current Liabilities and Total AssetsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.